Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Actym Therapeutics and Wacker Biotech Sign Manufacturing Contract for Actym's Lead Candidate for the Treatment of Solid Tumors

Tuesday, March 01, 2022

Actym Therapeutics a biotechnology company focused on the discovery and development of novel therapies intended to transform the treatment of cancer and Wacker Biotech announced today that they have signed a contract for the manufacturing of Actyms l...

Edenbridge Pharmaceuticals Announces the Launch of DARTISLA ODT

Tuesday, March 01, 2022

Edenbridge Pharmaceuticals LLC announced that DARTISLA ODT glycopyrrolate is now available by prescription in the United States through Phil the commercialization partner and eHub for DARTISLA ODT as well as in retail pharmacies throughout the countr...

Virios Therapeutics Announces Research Collaboration Exploring the Potential of Combination Antiviral Therapy for Treating Long COVID

Monday, February 28, 2022

Virios Therapeutics Inc a developmentstage biotechnology company focused on advancing novel antiviral therapies to treat chronic diseases including fibromyalgia announced today a collaboration with the Bateman Horne Center BHC of Salt Lake City Utah...

Taro Completes Acquisition of Alchemee

Monday, February 28, 2022

Taro Pharmaceutical Industries Ltd today announced the completion of its acquisition of Alchemee formerly The Proactiv Company TPC from Galderma The acquisition includes Alchemees business and assets worldwide including the Proactiv brand This acquis...

GliaPharm SA and the Wyss Center Enter Collaboration to Develop New Therapies for Alzheimer’s Disease

Friday, February 25, 2022

GliaPharm SA a biotech company that specializes in the research and development of novel therapies to treat and prevent neurological diseases and the Wyss Center a nonprofit organization dedicated to accelerating discoveries in neuroscience to improv...

GI Innovation Signs MoU With Cellkey for Biomarker Joint Research to Develop Next-generation Innovative Immuno-oncology

Friday, February 25, 2022

GI Innovation an innovative new drug development company announced on February that it has signed a biomarker joint research MoU with CellKey a Glycoprotein biomarker development company to develop nextgeneration innovative immunooncology The MoU ce...

Moderna and Thermo Fisher Scientific Announce Long-Term Strategic Collaboration

Thursday, February 24, 2022

Moderna Inc a biotechnology company pioneering messenger RNA mRNA therapeutics and vaccines and Thermo Fisher Scientific Inc the world leader in serving science today announced a year strategic collaboration agreement to enable dedicated largescale m...

Alvotech and Fuji Pharma Expand Partnership for Additional Biosimilar Candidate in Japan

Thursday, February 24, 2022

Alvotech Holdings SA a global biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients worldwide and Japanese pharmaceutical company Fuji Pharma announced today that they have agreed to add to t...

Algernon Pharmaceuticals Begins Manufacturing of Repirinast and Launches New Chronic Kidney Disease Research Program

Thursday, February 24, 2022

Algernon Pharmaceuticals Inc a clinical stage pharmaceutical development company is pleased to announce that it has awarded a contract to Zhejiang Ausun Pharmaceutical CO LTD of China to begin the manufacturing of a cGMP supply of its repurposed drug...

Kiniksa Pharmaceuticals and Huadong Medicine Announce Strategic Collaboration

Wednesday, February 23, 2022

Kiniksa Pharmaceuticals Ltd a biopharmaceutical company with a portfolio of assets designed to modulate immunological pathways across a spectrum of diseases and Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd a whollyowned subsidiary of Huadong Medic...